Pallas Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,622
| Closed | -$570K | – | 792 |
|
|
2024
Q4 | $570K | Sell |
6,622
-98
| -1% | -$8.43K | 0.02% | 342 |
|
|
2024
Q3 | $766K | Buy |
6,720
+64
| +1% | +$7.29K | 0.03% | 269 |
|
|
2024
Q2 | $865K | Sell |
6,656
-80
| -1% | -$10.4K | 0.04% | 224 |
|
|
2024
Q1 | $865K | Sell |
6,736
-2,018
| -23% | -$259K | 0.04% | 221 |
|
|
2023
Q4 | $906K | Buy |
8,754
+1,550
| +22% | +$160K | 0.05% | 214 |
|
|
2023
Q3 | $694K | Buy |
+7,204
| New | +$694K | 0.04% | 202 |
|
|
2022
Q2 | – | Sell |
-4,170
| Closed | -$246K | – | 241 |
|
|
2022
Q1 | $246K | Sell |
4,170
-2,818
| -40% | -$166K | 0.03% | 217 |
|
|
2021
Q4 | $333K | Sell |
6,988
-1,046
| -13% | -$49.8K | 0.04% | 239 |
|
|
2021
Q3 | $464K | Buy |
8,034
+2,496
| +45% | +$144K | 0.05% | 239 |
|
|
2021
Q2 | $272K | Buy |
+5,538
| New | +$272K | 0.04% | 260 |
|